Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
February 5, 2019
Sponsor: LANZA
Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
February 5, 2019
Sponsor: LANZA
Relates to an information card on the distribution of opioid antagonists
May 23, 2014
Sponsor: MARCHIONE
Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
March 27, 2025
Sponsor: LANZA
Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
April 13, 2021
Sponsor: LANZA
Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
February 14, 2023
Sponsor: LANZA
Relates to requiring homeless shelters to keep an opioid antagonist on hand, have at least one trained employee on duty at all times, and develop a training plan for opioid overdoses
January 17, 2023
Sponsor: CLEARE
Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
March 10, 2016
Sponsor: HANNON
Provides outpatient insurance coverage for non-pharmacological treatments and non-opioid drugs for chronic pain
January 24, 2025
Sponsor: RIVERA
Relates to presumptions for injured workers in opioid overdose claims for compensation
February 2, 2023
Sponsor: SCARCELLA-SPANTON
Relates to consideration and prescription of non-opioid treatment alternatives for treatment of neuromusculoskeletal conditions
February 8, 2021
Sponsor: RIVERA